Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Salmi, Q. A.
Right arrow Articles by Fan, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Salmi, Q. A.
Right arrow Articles by Fan, L. L.
(Chest. 2005;127:403-407.)
© 2005 American College of Chest Physicians

Serum KL-6 and Surfactant Proteins A and D in Pediatric Interstitial Lung Disease*

Qasem A. Al-Salmi, MD; Joseph N. Walter, MD; Giuseppe N. Colasurdo, MD; Marianna M. Sockrider, MD; E. O’Brian Smith, PhD; Hiroki Takahashi, MD and Leland L. Fan, MD

* From the Department of Pediatrics (Drs. Al-Salmi, Walter, Sockrider, Smith, and Fan), Baylor College of Medicine, Houston, TX; Department of Pediatrics (Dr. Colasurdo), University of Texas-Houston Medical School, Houston, TX; and Third Department of Internal Medicine (Dr. Takahashi), Sapporo Medical University School of Medicine, Sapporo, Japan.

Correspondence to: Leland L. Fan, MD, Texas Children’s Hospital, CC 1040.00, 6701 Fannin, Houston, TX 77030-2399; e-mail: llfan{at}texaschildrenshospital.org

Objective: To determine if serum KL-6, surfactant protein A (SP-A), and surfactant protein D (SP-D) levels are elevated in pediatric interstitial lung disease (ILD) and associated with pulmonary function and disease severity score.

Methods: Serum KL-6, SP-A, and SP-D levels were measured by enzyme-linked immunosorbent assay in 10 children with ILD and in 10 healthy volunteers. In the ILD group, FEV1 percentage of predicted, FVC percentage of predicted, and ILD disease severity score were measured and correlated with serum KL-6, SP-A, and SP-D levels.

Results: For the ILD and control groups, respectively, mean serum KL-6 was 4,523 U/mL and 206 U/mL (p = 0.007), mean serum SP-A was 133 ng/mL and 21 ng/mL (p = 0.003), and mean serum SP-D was 304 ng/mL and 75 ng/mL (p = 0.004). There was an inverse relationship between SP-A and FVC (p = 0.05), and between SP-D and FEV1 (p = 0.05). There was a direct relationship between SP-D and ILD score (p = 0.05).

Conclusions: Serum KL-6, SP-D and SP-D levels are elevated in children with ILD. SP-A and SP-D levels appear to correlate with some measures of disease severity.

Key Words: children • interstitial lung disease • KL-6 • pneumoprotein • surfactant protein A • surfactant protein D






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.